Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Egan

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical & Experimental Metastasis|June 20, 2014
Living in shear: platelets protect cancer cells from shear induced damageKarl Egan, Niamh Cooke, Dermot Kenny
Biochemical Society Transactions|November 10, 2015
Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impactKarl Egan, Barry Kevane, Fionnuala Ní Áinle
Clinical Chemistry and Laboratory Medicine|November 13, 2015
Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medicationEimear Dunne, Karl Egan, Siobhán McFadden, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Liver stiffness and thrombin generation in compensated cirrhosisAudrey Dillon, Karl Egan, Barry Kevane, et al.
Proteomics|March 21, 2017
Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitationsPaulina B Szklanna, Kieran Wynne, Marie Nolan, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?Barry Kevane, Karl Egan, Seamus Allen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 14, 2016
Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined SignificanceMaeve P Crowley, Barry Kevane, Susan I O'Shea, et al.
Cancer Medicine|October 25, 2013
Increased platelet reactivity in patients with late-stage metastatic cancerNiamh M Cooke, Karl Egan, Siobhan McFadden, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2016
Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activationKarl Egan, Audrey Dillon, Eimear Dunne, et al.
Proteomics. Clinical Applications|October 16, 2018
The Platelet Releasate is Altered in Human PregnancyPaulina B Szklanna, Martin E Parsons, Kieran Wynne, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical & Experimental Metastasis|June 20, 2014
Living in shear: platelets protect cancer cells from shear induced damageKarl Egan, Niamh Cooke, Dermot Kenny
Biochemical Society Transactions|November 10, 2015
Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impactKarl Egan, Barry Kevane, Fionnuala Ní Áinle
Clinical Chemistry and Laboratory Medicine|November 13, 2015
Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medicationEimear Dunne, Karl Egan, Siobhán McFadden, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Liver stiffness and thrombin generation in compensated cirrhosisAudrey Dillon, Karl Egan, Barry Kevane, et al.
Proteomics|March 21, 2017
Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitationsPaulina B Szklanna, Kieran Wynne, Marie Nolan, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?Barry Kevane, Karl Egan, Seamus Allen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 14, 2016
Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined SignificanceMaeve P Crowley, Barry Kevane, Susan I O'Shea, et al.
Cancer Medicine|October 25, 2013
Increased platelet reactivity in patients with late-stage metastatic cancerNiamh M Cooke, Karl Egan, Siobhan McFadden, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2016
Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activationKarl Egan, Audrey Dillon, Eimear Dunne, et al.
Proteomics. Clinical Applications|October 16, 2018
The Platelet Releasate is Altered in Human PregnancyPaulina B Szklanna, Martin E Parsons, Kieran Wynne, et al.
Pageof 2